NCT02494258 2025-05-22A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological DisordersCelgenePhase 2 Completed5 enrolled
NCT03814005 2024-09-05A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsTakedaPhase 1 Completed17 enrolled 33 charts
NCT04629443 2024-06-06Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid LeukaemiaServierPhase 1/2 Completed17 enrolled 19 charts
NCT03941964 2023-03-20A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyAbbViePhase 3 Completed60 enrolled 12 charts
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT01201811 2019-12-05Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)CelgenePhase 4 Completed44 enrolled 26 charts
NCT01545947 2019-11-12Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung CancerCelgenePhase 1 Completed76 enrolled